| 000 | 01617 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516173643.0 | ||
| 264 | 0 | _c20141022 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1468-1293 | ||
| 024 | 7 |
_a10.1111/hiv.12089 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Mulder, M | |
| 245 | 0 | 0 |
_aHIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA. _h[electronic resource] |
| 260 |
_bHIV medicine _cMar 2014 |
||
| 300 |
_a135-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xadverse effects |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xblood |
| 650 | 0 | 4 |
_aHIV-1 _xclassification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhylogeny |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 |
_apol Gene Products, Human Immunodeficiency Virus _xmetabolism |
| 700 | 1 | _aYork, V A | |
| 700 | 1 | _aWiznia, A A | |
| 700 | 1 | _aMichaud, H A | |
| 700 | 1 | _aNixon, D F | |
| 700 | 1 | _aHolguin, A | |
| 700 | 1 | _aRosenberg, M G | |
| 773 | 0 |
_tHIV medicine _gvol. 15 _gno. 3 _gp. 135-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/hiv.12089 _zAvailable from publisher's website |
| 999 |
_c23158522 _d23158522 |
||